Pluvicto 1,000 MBq/mL (27 mCi/mL) injection Images

Generic Name: lutetium lu 177 vipivotide tetraxetan

This medication has been identified as Pluvicto 1,000 MBq/mL (27 mCi/mL) injection. It is supplied by Advanced Accelerator Applications USA, Inc.

Pluvicto is used in the treatment of Prostate Cancer and belongs to the drug class therapeutic radiopharmaceuticals. Pluvicto 1,000 MBq/mL (27 mCi/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Pluvicto

Generic Name

lutetium lu 177 vipivotide tetraxetan

Strength

1,000 MBq/mL (27 mCi/mL) injection

Availability

Prescription only

Drug Class

Therapeutic radiopharmaceuticals

CSA Schedule

Not a controlled drug

Labeler / Supplier

Advanced Accelerator Applications USA, Inc.

Manufacturer

Novartis Pharmaceuticals Corporation

National Drug Code (NDC)

69488-0010

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer